balsalazide has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, YS; Kim, DS; Kim, JK; Kim, WJ; Lee, DH | 1 |
| Forbes, WP; Gordon, GL; Huang, S; Lamet, M; Mareya, S; Pruitt, R; Scherl, EJ; Shaw, A | 1 |
1 trial(s) available for balsalazide and Disease Exacerbation
| Article | Year |
|---|---|
Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Prospective Studies; Rectum; Severity of Illness Index; Sigmoidoscopy; Tablets; Treatment Outcome | 2009 |
1 other study(ies) available for balsalazide and Disease Exacerbation
| Article | Year |
|---|---|
Efficacy of topical 5-aminosalicylate monotherapy in patients with ulcerative proctitis with skip inflammation.
Topics: Administration, Ophthalmic; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Maintenance Chemotherapy; Male; Mesalamine; Middle Aged; Phenylhydrazines; Proctocolitis; Remission Induction; Treatment Outcome; Young Adult | 2018 |